It has been demonstrated that mutations of the IDH1 and IDH2 gene (IDH1R132, IDH2R172) in glioblastomas are associated with the production of the TET inhibiting oncometabolite 2-hydroxyglutarate [17], [18], [19]. The gene discussed is IDH2; the disease is glioblastoma.